Ropivacaine (mixed presentations): Hospital supply issue
This issue affects three presentations of Ropivacaine Kabi.
21 October 2026 | Supply returned to normal
The supplier once again has ample stock of all strengths of ropivacaine
Affected product
Because of constraints in the manufacturing plant, Fresenius Kabi has limited supplies of some ropivacaine presentations. Shipments continue to arrive, however supply continues to be constrained. The most affected products are as follows.
|
Presentation |
Pharmacode |
Supply status |
|---|---|---|
|
2 mg/ml, 100 ml bag |
2479125 |
Stock available |
|
2 mg/ml, 200 ml bag |
2479117 |
Stock available |
|
7.5mg/ml 10 ml amp |
2478722 |
Stock available |
|
7.5mg/ml 20 ml amp |
2478730 |
Stock available |
Other presentations remain available.
Ropivacaine listings in the HML(external link)
Shipments
Stock levels of ropivacaine have returned to normal.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)